Table 1.
Summary of the number of in vivo toxicity studies evaluated for their relevance and reliability
Studies assessed for their relevance | Studies considered relevant | Studies considered with reliability 1 and 2 | ||
---|---|---|---|---|
Relevant for hazard characterisation | Relevant for providing supporting evidence | |||
Studies examining toxicity effect in the liver, spleen and pancreas | 56 | 32 | 3 | 3 |
Studies examining toxicity effect in heart and kidney | 27 | 10 | 3 | 2 |
Studies examining other organs | 37 | 14 | 5 | 3 |
Reproductive and developmental toxicity studies | 39 | 29 | 4 | 3 |
Neurotoxicity and developmental neurotoxicity studies | 24 | 17 | 6 | 6 |
Inflammation and immunotoxicity studies | 38 | 30 | 9 | 8 |
Gut microbiota | 16 | 13 | 8 |